[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"myofascial-trigger-point-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:myofascial-trigger-point-pain":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,39,62,87],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100639406","effect-of-integrated-neuromuscular-inhibition-technique-on-hand-grip-strength-in-upper-trapezius-myofascial-trigger-points-100639406",false,"NCT07591259","Effect of Integrated Neuromuscular Inhibition Technique on Hand Grip Strength in Upper Trapezius Myofascial Trigger Points","Inclusion Criteria:\n\n* Subjects will be selected from out patient clinic of Delta University hospital, Dakahlia, Egypt.\n* Subjects aged between 18 and 55 years.\n* Their body mass index (BMI) were ranged from 18-30 kg\u002Fm2.\n* Subjects diagnosed as myofascial pain syndrome with a unilateral upper trapezius myofascial trigger point on the dominant side by a physician.\n* Subjects must have characteristics of trigger points: hardened, thickened taut bands in MPS patients. Contraction knots within taut muscle bands are pathognomonic features of MTrPs. Common features of the trigger point include the tender bands of muscles, taut band which could produce pain while pressing it directly or sometimes spontaneous, with this there was weak muscles, sensory motor dysfunctions, changes in motor control function and disruption of normal patterns of motor recruitments are seen.\n* Subjects from both genders.\n* The severity of pain on the visual analogue scale should be higher than two out of ten.\n* Patients will receive all standard medical treatment.\n\nExclusion Criteria:\n\n* A history of any major neurological or musculoskeletal disorders, cardiovascular or respiratory diseases.\n* Neck pain due to cervical spine pathology.\n* Any history of cervical trauma, fractures or dislocations, carcinoma.\n* Uncooperative behavior, and unwillingness to participate.\n* Wrist problems (stiffness, fracture, operation or carpal tunnel syndrome).","ALL","18 Years","55 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aims to investigate the effects of the integrated neuromuscular inhibition technique on patients with upper trapezius myofascial trigger points by evaluating its impact on neck pain intensity, pressure pain threshold, hand grip strength, pinch grip strength, wrist joint range of motion, and upper extremity function.",[26],"Myofascial Trigger Point Pain","NOT_YET_RECRUITING","2026-05-09",{"date":30,"type":31},"2026-05-15","ACTUAL",{"date":30,"type":20},{"date":34,"type":20},"2026-09-22",{"name":36,"class":37},"Cairo University","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":46,"enrollmentInfo":47,"targetDuration":4,"studyType":21,"phases":49,"briefSummary":50,"conditions":51,"keywords":4,"overallStatus":52,"whyStopped":4,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":38},"100542103","the-effectiveness-of-dry-needling-treatment-in-patients-diagnosed-with-dorsal-myofascial-pain-syndrome-100542103","NCT06338514","The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.","The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsalgia Accompanied by Myofascial Pain Syndrome.","Inclusion Criteria:\n\n* Clinically diagnosed with Dorsal Myofascial Pain Syndrome associated with rhomboid and trapezius trigger point.\n* Having a shoulder pain Visual Analog Scale (VAS) score of 6 or higher.\n* Ability to read and write\n\nExclusion Criteria:\n\n* History of spinal surgery.\n* Lesions, atrophy, or scars in the skin around the back.\n* Undergoing physiotherapy targeting the back and lumbar region in the last 6 months.\n* Undergoing an interventional procedure for back or lumbar pain in the last 3 months.\n* Use of steroids in the last 1 month.\n* Special conditions such as epilepsy, pregnancy, injection phobia, etc.\n* Inability to comply with the restriction on the use of steroid and non-steroidal anti-inflammatory drugs during the treatment period.","80 Years",{"count":48,"type":20},50,[23],"Back pain is commonly seen in the working-age population, with the peak occurrence around the age of 40. Its frequency does not increase with age and is not associated with age-related degenerative changes in the spine. Especially when the underlying cause is conditions such as myofascial pain syndrome (MPS), where regional muscle sensitivity in the rhomboid and trapezius areas is prominent, dry needling treatment has become increasingly popular and the subject of numerous studies in recent years. In the diagnosis of MPS, two valuable findings include the detection of a taut band upon palpation and the presence of trigger points in muscle fibers with mild finger pressure. The study we are planning involves a double-blind efficacy trial where real and sham dry needling procedures will be performed under ultrasound guidance, ensuring that both the patient and the evaluator are blinded. This study design has the potential to make a significant contribution to the literature in this field.",[26],"RECRUITING","2025-08-26",{"date":55,"type":31},"2025-09-03",{"date":57,"type":31},"2024-04-25",{"date":59,"type":20},"2025-11-10",{"name":61,"class":37},"Kutahya Health Sciences University",{"id":63,"slug":64,"hasResults":11,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":4,"eligibilityCriteria":67,"healthyVolunteers":11,"sex":15,"minAge":68,"maxAge":4,"enrollmentInfo":69,"targetDuration":4,"studyType":21,"phases":71,"briefSummary":72,"conditions":73,"keywords":74,"overallStatus":52,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":38},"100472280","the-therapeutic-effects-of-dextrose-injection-for-myofascial-pain-syndrome-100472280","NCT05429827","The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome","Inclusion Criteria:\n\n* 1). Patients should be 20 years of age or older;\n* 2). They are able to communicate freely;\n* 3). Patients have the diagnosis of myofascial pain syndrome (MPS) with a definite myofascial trigger point (MTrP) in the neck base and upper back regions (the upper trapezius muscle). The MTrP is identified based on the following criteria, as recommended by Simons \\[Simons et al., 1999\\]:\n\n  * (a). a localized tender spot in a palpable taut band of muscle fibers,\n  * (b). recognized pain (as the usual clinical complaint) when the tender spot is compressed,\n  * (c). characteristic and consistent referred pain.\n* 4). Symptoms of MPS should be more than 3 weeks.\n\nExclusion Criteria:\n\n* (1). acute or serious medical problems;\n* (2). cognitive impairment or psychiatric disorder;\n* (3). coagulopathy or any other bleeding disorder;\n* (4). taking medication of anticoagulation or antithrombolytics;\n* (5). sensory deficiency over the body part where MTrPs located;\n* (6). serum hepatitis B or acquired immunodeficiency syndrome;\n* (7). malignancy;\n* (8). pregnant or likely to be pregnant.\n* (9). diabetes mellitus","20 Years",{"count":70,"type":20},30,[23],"Patients with an myofascial trigger point (MTrP) in their upper trapezius will be divided into three groups: Group A receiving MTrP injection with normal saline (control group), Group B with hypo-osmolar dextrose (5% dextrose), and Group C with hyper-osmolar dextrose (15% dextrose). Clinical outcomes and morphological changes will be measured before the injection, one hour after, one week after, two weeks after, and one month after the injection to delineate the therapeutic effects of dextrose injection for an MTrP.",[26],[75,76,77],"myofascial trigger point","endplate noise","dextrose.","2024-12-30",{"date":80,"type":31},"2025-01-01",{"date":82,"type":31},"2022-11-18",{"date":84,"type":20},"2025-12-31",{"name":86,"class":37},"National Cheng-Kung University Hospital",{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":4,"eligibilityCriteria":93,"healthyVolunteers":11,"sex":94,"minAge":16,"maxAge":95,"enrollmentInfo":96,"targetDuration":4,"studyType":21,"phases":98,"briefSummary":99,"conditions":100,"keywords":105,"overallStatus":52,"whyStopped":4,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":38},"100553904","myofascial-release-technique-in-women-with-primary-dysmenorrhea-100553904","NCT06492148","Myofascial Release Technique in Women With Primary Dysmenorrhea","Effect of Myofascial Release Technique on Central Sensitization, Myofascial Trigger Point and Menstrual Symptoms in Women With Primary Dysmenorrhea: Sham-Controlled, Randomized Double-Blind Study","Inclusion Criteria:\n\n* Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide,\n* Having regular menstruation in the last 6 months (28±7 days)\n* Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months\n\nExclusion Criteria:\n\n* Diagnosed with Secondary Dysmenorrhea,\n* Having given birth,\n* Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes,\n* Undergoing urogynecological surgery,\n* Those who are pregnant or suspected of pregnancy,\n* Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain,\n* Those using intrauterine or oral contraceptives,\n* Those taking extra supplements such as magnesium, which may affect treatment","FEMALE","35 Years",{"count":97,"type":20},36,[23],"It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.",[101,102,26,103,104],"Dysmenorrhea Primary","Central Sensitisation","Menstrual Discomfort","Myofascial Release",[106,107,108,109,110],"myofascial release","trigger point","Central sensitization","Dysmenorrhea","sham","2024-11-19",{"date":113,"type":31},"2024-11-21",{"date":115,"type":31},"2024-09-10",{"date":117,"type":20},"2025-09-25",{"name":119,"class":37},"Gazi University"]